Renal fibrosis, especially tubulointerstitial fibrosis, is the inevitable outcome of all progressive chronic kidney diseases (CKDs) and exerts a great health burden worldwide. For a long time, interests in renal fibrosis have been concentrated on fibroblasts and myofibroblasts. However, in recent years, growing numbers of studies have focused on the role of tubular epithelial cells (TECs). TECs, rather than a victim or bystander, are probably a neglected mediator in renal fibrosis, responding to a variety of injuries. The maladaptive repair mechanisms of TECs may be the key point in this process. In this review, we will focus on the role of TECs in tubulointerstitial fibrosis. We will follow the fate of a tubular cell and depict the intracellular changes after injury. We will then discuss how the repair mechanism of tubular cells becomes maladaptive, and we will finally discuss the intercellular crosstalk in the interstitium that ultimately proceeds tubulointerstitial fibrosis.
Introduction
Chronic kidney diseases (CKDs) have exerted a great burden on public health worldwide. According to the WHO estimate, CKD accounted for 1.5% of deaths worldwide in 2012 1 . Renal fibrosis, especially tubulointerstitial fibrosis (TIF), is the inevitable outcome of all progressive CKD 2 , and therefore, exploring the intrinsic mechanisms of TIF is of great importance. TIF is manifested by tubular atrophy and the accumulation of extracellular matrix (ECM) 3 . For a long time, interests have focused on fibroblasts and myofibroblasts. However, in recent years, a growing number of studies are shedding light on the role of tubular epithelial cells (TECs) in renal fibrosis 4 . Evidence has shown that TECs, rather than being victims or bystanders, are probably an initiator of the TIF response to a variety of injuries 5 . The maladaptive repair mechanisms of TECs can be the key point of progression from acute to chronic disease 6 . In this review, we will focus on the role of TECs as an important mediator of TIF upon injury.
What are the intracellular changes of TECs upon injury?

Mitochondria dysfunction and reactive oxygen species (ROS) aggravate tubular injury
Mitochondrial impairment may aggravate TEC injury by disturbing energy metabolism and activating ROS and NLR family pyrin domain containing 3 (NLRP3)/inflammasomes ( Fig. 1) . A genome-wide transcriptome study on kidney biopsy specimens with TIF showed the deposition of lipid in TECs along with decreased expression of enzymes related to fatty acid oxidation (FAO) 7 . Inhibition of FAO leads to a fibrotic phenotype change in TECs, while restoring FAO attenuates TIF 7 . The impairment of FAO is attributed to the downregulation of peroxisome proliferator-activated receptor α (PPARα) and overexpression of miR-21 [8] [9] [10] . The loss of FAO also drives a metabolic switch to glycolysis in TECs to meet energy demands 11 . Impaired mitochondrial function also leads to the production of ROS and oxidative stress in TECs 8, 12 . Studies on diabetic nephropathy (DN) show that the accumulation of advanced oxidation protein products (AOPPs) results in mitochondrial injury and oxidative stress 12 . Production of ROS in the mitochondria can further lead to the activation of NLRP3 [13] [14] [15] . Two earlier studies showed increased mitochondrial ROS production along with NLRP3/inflammasome activation. Inhibition of mitochondrial ROS production simultaneously inhibits the activation of NLRP3 and downstream interleukin-1β (IL-1β) and IL-18 production, indicating the presence of mitochondrial ROS prior to the activation of NLRP3 13,14, . A recent study showed that this process is probably mediated by the mROS-TXNIP-NLRP3 pathway 15 . Mitochondrial ROS can also increase the expression of several other proinflammatory and profibrotic factors, including monocyte chemoattractant protein-1 (MCP-1), plasminogen activator inhibitor and transforming growth factor beta 1 (TGF-β1) 16 . These results indicate that improving normal mitochondrial function may attenuate renal fibrosis. Recent studies prove the potential renoprotective role of several intrinsic modulation factors that are closely related to mitochondrial function. Either downregulation of dynamin-related protein 1 (DRP1) 17 or upregulation of NAD-dependent deacetylase sirtuin-3, mitochondrial (SIRT3) 18 or TNF receptor associated protein 1 (TRAP1) 19 could have a protective effect on mitochondrial function in TECs and ameliorate renal fibrosis. Mitochondria undergo metabolic disorders, manifested by decreased fatty acid oxidation. Mitochondria can also produce ROS and further activate the NLRP3/inflammasome. Production of mitochondrial ROS is also related to the expression of proinflammatory factors. ER stress caused by misfolded proteins can start the unfolded protein reaction (UPR), including activation of GRP78 and downstream signaling, including the PERK-eIF2-ATF4 pathway and ATF6 pathway. However, persistent activation of UPR can result in apoptosis. Autophagy plays a dual role. This process can either avoid apoptosis or aggravate renal fibrosis, depending on different situations. Injuries can also lead to epigenetic changes and changes in mRNA expression Endoplasmic reticulum (ER) stress and unfolded protein response (URP) are double-edge swords in tubular injury
Injuries by toxins, albuminuria, and metabolic disorders lead to accumulation of misfolded proteins in TECs and ER stress. ER stress is manifested by UPR 20 , an intrinsic adaptive process that helps cells survive. However, persistent activation of UPR may finally lead to apoptosis 21 . GRP78, a molecular chaperone that functions in protein folding, makes UPR a pro-survival mechanism (Fig. 1) . In an age-related proteinuria model, more severe TIF was observed in the aged group, together with a significantly suppressed GRP78 level, indicating the protective role of GRP78 22 . The binding of misfolded protein to GRP78 can start three pathways, the PRKR-like endoplasmic reticulum kinase-eukaryotic translation initiation factor 2-activating transcription factor 4 (PERK-eIF2-ATF4) pathway, inositol-requiring enzyme 1-X-Box binding protein 1 (IRE1-XBP1) pathway and activating transcription factor 6 (ATF6) pathway, which in turn can activate UPR and mediate cell repair 23 . A recent study has also found the involvement of the mitogen-activated protein kinase (MAPK/ERK) pathway in ER stress 24 . However, persistent injury and UPR activation can lead to cell apoptosis. This process is mediated by caspase-12, an ER-specific caspase, via activation of the caspase-9/caspase-3 cascade 20 . A recent study has also shed light on the profibrotic role of a novel ER-associated protein, RTN1A 21, 25 . RTN1A is related to prolonged ER stress and apoptosis of TECs 25 . Specific knockout of RTN1A in TECs could downregulate ER stress signaling and ameliorate ER stress-associated apoptosis 21 . Recognition of these facts has also offered some possible approaches for the diagnosis and treatment of renal fibrosis. Urinary cysteine-rich with EGF-like domains 2, a molecule induced and secreted upon ER stress from podocytes and TECs, could be a prospective predictor of tubulointerstitial injury 26 . The chemical chaperon sodium 4-phenylbutyrate can mimic the role of an ER chaperone in vivo and greatly reduce TECs apoptosis and renal fibrosis caused by ER stress 27 . Another molecule, HMGCoA reductase degradation 1 homolog (HRD1), an E3 ubiquitin ligase, can also ameliorate TEC apoptosis by promoting ubiquitylation and degradation of eIF2alpha, a critical protein in the PERK-eIF2alpha-ATF4-CHOP signaling pathway 28 .
Autophagy exerts bidirectional effects on TECs upon injury
Autophagy is a mechanism that engulfs unnecessary or dysfunctional cellular components and can help TECs adapt to a variety of injuries; [29] [30] [31] however, persistent activation of autophagy leads to fibrosis (Fig. 1) . In DN, the specific inhibition of autophagy results in the accumulation of advanced glycation end products along with worsened inflammation and fibrosis
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. Two other studies focusing on DN also found an association between decreased autophagy and renal fibrosis, and this process is probably the result of inhibition of phosphatase and tensin homolog (PTEN) by Notch1/Hes1 in response to high glucose concentrations 32, 33 . Another in vitro study showed that enhanced autophagy ameliorates fibrosis induced by TGF-β1 30 . Increased autophagy is observed along with decreased apoptosis 31 . One study has also shown that autophagy is partly regulated by ER stress to improve renal function and histology 34 . Two studies focusing on the role of Atg5 had controversial results 35, 36 . One showed that genetic deletion of Atg5-mediated autophagy specifically in TECs leads to marked cell cycle arrest, increased COL1 deposition, and severe interstitial fibrosis in an unilateral ureteral obstruction (UUO) model 37 . However, the other study on Atg5 indicated that the ablation of autophagy in TECs leads to significantly less tubular senescence and reduced interstitial fibrosis 30 days after ischemia-reperfusion injury 35 . Moreover, another study investigating kidney proximal tubule-specific Atg7 knockout mice also showed ameliorated tubular injury and TIF 36 . These results indicate the two-way effect of autophagy in renal fibrosis. Indeed, autophagy can degrade unnecessary or dysfunction components and prevent cell apoptosis. However, some severely damaged TECs that should have undergone apoptosis may also manage to survive via autophagy. These cells undergo maladaptive repair and phenotype changes, thereby becoming sources of proinflammatory and profibrotic cytokines, leading to aggravated renal fibrosis 35 .
Epigenetic changes in TECs provide new therapeutic insights
One study on DN revealed a switch in DNA methylation and changes of mRNA expression of select genes, thereby leading to phenotype changes of TECs 38 . Another study showed increased H3K9 histone markers after UUO, indicating that epigenetics may play a role in fibrogenesis 39 . The possible involvement of epigenetics provides a new aspect of treatment for renal fibrosis (Fig. 1) . Two research groups using either MS 275 or valproic acid (VPA) demonstrated that the class I histone deacetylase (HDAC) inhibitor could effectively ameliorate renal fibrosis caused by UUO 40, 41 . A recent study applied DZNep (3-deazaneplanocin A), an H3K27me3 inhibitor, in an ischemia-reperfusion model. TECs harvested from the model were examined with high-throughput sequencing (RNA-seq). The study showed that profibrotic genes such as COL3A1 (collagen type 3a1) and TIMP2 (tissue inhibitor of metalloproteinase 2) are suppressed by DZNep in vivo 42 , demonstrating the efficacy of the treatment at the RNA level. Epigenetic changes in TECs may be an important research area for investigating the mechanisms of, or the therapeutic approaches for, renal fibrosis.
Important signaling pathways involved in renal fibrosis
A great number of intracellular pathways are involved in TECs upon injury (Table 1) , of which the TGF-beta1/ Smad3 pathway [43] [44] [45] , RAS pathway [46] [47] [48] , and Wnt/betacatenin pathway 49, 50 are the most well established. In addition to these, several other pathways are also involved, including the p38 MAPK pathway 24, 51, 52 , phosphatidylinositide 3-kinases/protein kinase B (PI3K/AKT) pathway [53] [54] [55] [56] [57] , epidermal growth factor receptor (EGFR) pathway [58] [59] [60] , Hippo-Salvador pathway 61 , Notch pathway 33, 62 , c-Jun N-terminal kinases (JNK) pathway 63 , Sonic hedgehog pathway 64 , adiponectin/adiponectin receptor 1 (APN/AdipoR1) pathway 65 , membrane rafts-redox pathway, etc 66 . Each signaling pathway may exert partial influences that drive the cell to play either a profibrotic or antifibrotic role, whereas different pathways can interact with each other at different levels, forming an intricate signaling network that regulates the progression of renal fibrosis after different injuries. The fact that the signaling pathways regulating renal fibrosis are still not well understood urges thorough investigation. A more comprehensive description of the regulation network will provide us with more potential targets for preventing or even reversing renal fibrosis.
How do repair mechanisms become maladaptive and result in renal fibrosis?
TECs can adopt different mechanisms upon insult and manage to regenerate and regain normal kidney function if the injury is mild and transient 67, 68 . However, if the injury is severe and persistent, normal regeneration mechanisms may not function, and TECs might undergo maladaptive repair, exacerbating renal fibrosis 67, 69, 70 ( Fig. 2) . Renal fibrosis can be seen as the final consequence of improper repair mechanisms, in other words, maladaptive repair. A recent study demonstrated that it is the severity and frequency of TEC injury that determine whether the repair mechanism leads to recovery or progression to fibrosis 71 . Although adaptive repair shows profound proliferation of TECs 68 , the maladaptive response is characterized by interstitial fibrosis, tubular atrophy, and capillary rarefaction 69 .
Cell senescence is the marker for maladaptive tubular cells
Maladaptive tubular cells manifest cell senescence [68] [69] [70] , which is defined as the absence of the ability to divide and a permanently arrested cell cycle 68, 72 . The senescence of tubular cells has been observed in CKDs induced by hypertension, diabetes, and IgA nephropathy 67 . Senescence is also observed in cell ageing. Aged mice cells have decreased cellular proliferation and increased senescence compared with young mice subjected to ischemia-reperfusion injury 73 . A proteomic study on human proximal TECs also shows increased senescence in older cells 74 . Senescence has two characteristics, cell cycle arrest at the G2/M phase and the secretion of proinflammatory and profibrotic factors; 67, 68, 70 the latter is also known as senescence-associated secretory phenotype. These two changes are the bridges that link tubular cell senescence with renal fibrosis.
An arrested cell cycle at the G2/M phase promotes renal fibrosis As mentioned above, cell cycle arrest is one of the most important characteristics of cell senescence. It is the consequence of maladaptive repair by tubular cells and has a strong correlation with renal fibrosis. In uninjured kidneys, most tubular cells remain in the quiescent G0 phase. Upon insult, TECs enter the cell cycle to regenerate and replace the cells lost during injury 4 . Some cells are arrested at the G1 or G2 phase for DNA repair. However, persistent cell cycle arrest is a kind of maladaptive repair and has a strong association with the progression of renal fibrosis 67, 68, 70 . The fact that aged mice have more severe cellular senescence and fibrosis after AKI can also be explained by the increased number of cells arrested at the G2/M phase due to increased DNA damage 73 . P53, p21, and p16
INK4a have been recognized as the most important factors involved in this process 5, 68, 69 . P21 is upregulated shortly after acute kidney injury (AKI). It is renoprotective in the early phase since it can halt the cell cycle to repair DNA damage, which prevents tubular cells from undergoing apoptosis 69 . The fact that p21 knockout mice have more severe damage after AKI also demonstrates the protective role of p21 in the early-phase after injury 68 . However, persistent expression of p21 and cell cycle arrest may lead to cell senescence and aggravate fibrosis. Apart from AKI, hypoxia can also induce p21 expression and lead to G2/M phase arrest via the ataxiatelangiectasia-mutated-ataxia telangiectasia and Rad3-related (ATM-ATR) pathway 69 . P16 INK4a is also upregulated in tubular cells upon injury and is responsible for mediating cell cycle arrest, since deleting p16
INK4a could restore cell proliferation after AKI 69 . P53, the upstream regulator of p21, is also upregulated after AKI, and inhibition of p53 expression attenuates renal fibrosis 68 . P53 is also activated in DN, and its activity is in negative correlation with renal function 75 . Apart from p53, p21, and p16
INK4a , modulation of cell cycle arrest involves more complex mechanisms. Atg5-mediated autophagy in TECs can ameliorate renal fibrosis by blocking G2/M phase arrest 37 . Macrophage migration inhibitory factor also counteracts cell cycle arrest 76 . On the other hand, miR-192 and Numb can aggravate cell cycle arrest and renal fibrosis either by upregulating or stabilizing p53 77, 78 . Cell cycle arrest is also correlated with the process of epithelial-mesenchymal transition (EMT), and overexpression of Twist1 or Snail is sufficient to prolong the G2/M arrest induced by TGF-β1 79 .
The arrested tubular cells can express factors like TGF-β1, connective tissue growth factor (CTGF), C-X-C motif chemokine ligand 1 (CXCL1), IL-6, and IL-8, partially mediated by the JNK pathway 70 . These factors promote a chronic inflammatory microenvironment that favors fibrosis 67 . Arrested tubular cells also fail to regenerate to replace the lost cells, leaving space for the proliferation of fibroblasts and deposition of ECM. All of these changes drive the interstitium to fibrosis and aggravate renal function.
EMT is a potential source of fibroblasts and ECM
EMT is referred to as the process that allows a polarized epithelial cell to assume a mesenchymal phenotype, which includes an enhanced migratory capacity, invasiveness, elevated resistance to apoptosis, and increased production of ECM components 80 . As mentioned above, TECs undergo dedifferentiation and regeneration to produce new tubular cells after injury. Meanwhile, they produce various factors that attract inflammatory cells to the tubulointerstitial space. Infiltrating cells express cytokines that further alter the tubulointerstitial microenvironment and force TECs to turn to a mesenchymal phenotype to adapt to these changes and avoid apoptosis 5, 72 . Moreover, this switch is also a potential source of fibroblasts and ECM deposition. Thus, the process of EMT becomes maladaptive and aggravates renal fibrosis. Fig. 2 Description of maladaptive repair. It is the severity and frequency of the injury that determine whether the repair mechanism adopted by tubular cells is beneficial or maladaptive. Severe and persistent injury exceeds normal repair mechanisms, and these cells become maladaptive to survive the injury. Maladaptive repair is manifested by cell cycle arrested at the G2/M phase and a senescence-associated secretory phenotype. The former is characterized by the expression of proteins that include p53, p21, and p16
INK4a
. The latter includes secretion of proinflammatory and profibrotic factors, including TGF-beta1, CTGF, CXCL1, IL-6, IL-8, etc. Tubular cells can also undergo EMT to avoid apoptosis, with loss of some epithelial markers (E-cadherin, ZO-1) and acquisition of partial myofibroblast markers (alpha-SMA, vimentin, FSP-1). This process involves changes in the immune microenvironment. Proinflammatory factors secreted by TECs recruit and activate different inflammatory cells, and these recruited cells can further produce cytokines that drive TECs to undergo EMT. TECs finally obtain a myofibroblast phenotype, express alpha-SMA, and are responsible for collagen synthesis and ECM deposition EMT is characterized by the loss of epithelial markers, including E-cadherin and zonula occludens-1 (ZO-1), and the acquisition of mesenchymal markers, including vimentin, alpha-SMA, fibroblast-specific protein-1 (FSP-1), collagen I and fibronectin 81 . Though it is widely accepted that EMT can be induced by TGF-β1 in vitro, whether this process contributes to the production of fibroblasts in vivo is still uncertain 82 . A possible explanation for this controversy could be changes in the definition of EMT 2 . In the past, researchers expected to find complete EMT in vivo, with the complete loss of epithelial markers and the acquisition of mesenchymal markers along with tubular cells traversing the basement membrane 83, 84 . However, recent research has shown that EMT, rather than an "all or none" process, is actually a spectrum of changes 2, 4, 5 . Tubular cells could lose some epithelial makers while acquiring partial mesenchymal markers. This process is termed partial EMT, which is more likely to occur in vivo 2 . Snail and Twist1 mediate this process 53, 85, 86 . Conditional deletion of Snai1 or Twist1 in TECs leads to inhibition of EMT 79 . The signaling pathway involved is complicated and overlaps with the pathways mediating renal fibrosis discussed above, including the TGF-β1/ Smad pathway, intergrin/integrin linked kinase (ILK) pathway, Wnt/beta-catenin pathway, p38 MAPK pathway, Sonic hedgehog pathway, and membrane rafts-redox pathway, etc. 51, 64, 81, 87 . TECs undergoing this phenotypic switch can attract inflammatory cells and activate fibroblasts and pericytes in a paracrine manner;
4,79 evidence also shows that they can serve as a direct producer of ECM that can aggravate TIF 88 . EMT and cell senescence, manifested by G2/M phase arrest, actually have much in common. Both occur after persistent injury and maladaptive repair; both go through the process of dedifferentiation, and the secretion of proinflammatory and profibrotic cytokines, which aggravates renal fibrosis, is seen in both. Though not confirmed by experiments, it may be reasonable to infer that they are both the consequences of maladaptive repair. Moreover, they may even be two inseparable facets of the same process, with EMT emphasizing phenotypic changes and senescence emphasizing cell cycle changes. However, more research is needed to prove a correlation between EMT and cell senescence and to provide new insights into therapeutic approaches for targeting maladaptive repair mechanisms.
Though most of the researches discussed above were conducted in native kidneys, the unique nature of kidney transplantation, for example, the ischemia injury during harvesting the kidney, immune-mediated injury, use of immunosuppressants, and sequential protocol biopsies make allograft an ideal target studying the correlation between TECs and renal fibrosis. The term "interstitial fibrosis/tubular atrophy (IF/TA)" is often used in transplant biopsies, given that these two phenomena almost inevitably occur in parallel 89, 90 . Most of the underlying mechanisms discussed above are also confirmed in allograft studies. Take EMT for example, extensive biopsy studies have demonstrated the mesenchymal phenotype change of tubular cells in vivo, which contributes to the progression of fibrosis in the allograft and is predictive for graft loss [91] [92] [93] . Growing numbers of studies are focusing on counteracting TIF to extend graft survival time. Mesenchymal stem cells have been confirmed to play a renoprotective role in transplanted kidneys by attenuating tubular atrophy and TIF [94] [95] [96] . Given the unique characteristics, renal allograft might be a promising model studying renal fibrosis in the future.
How do TECs interact with other cell types in the interstitium to advance renal fibrosis?
Growing evidence has shown that TECs are indispensable mediators in TIF; they must interact with other cells in the interstitium, including inflammatory cells, endothelial cells, fibroblasts, and pericytes, to drive the progression of fibrosis. Maladaptive TECs can either attract or activate these cells via crosstalk, and these interactions together cause the progression of TIF (Fig. 3) .
Crosstalk between TECs and inflammatory cells
Inflammation has been widely observed in a variety of CKD biopsy specimens and animal models and has been recognized as crucial for the initiation of renal fibrogenesis 2 . Among the inflammatory cells, the role of monocytes/macrophages is the most well-established.
Maladaptive TECs can secrete CCL2 and CCL5 to recruit monocytes and macrophages [97] [98] [99] . Peripheral monocytes that are recruited can differentiate into macrophages once they arrive at the renal interstitium 98 . Interestingly, a recent study demonstrates that recruited monocytes could instruct TECs to turn off chemokine secretion and downregulate the production of proinflammatory factors; 98 this self-limited negative feedback system indicates that monocyte may also play an important role in the resolution of inflammation. TECs can also recruit macrophages by secreting matrix metallopeptidase 9 (MMP-9) in the early stage after UUO, whereas recruited macrophages produce more MMP-9, which can aggravate the progression of EMT 100 . Once recruited, macrophages exert pleiotropic effects on renal fibrosis depending on the polarization form: a proinflammatory M1 phenotype or a reparative M2 phenotype 2 . It has been well documented that, shortly after AKI, predominant M1 macrophages can amplify damage, whereas the later M2 phenotype is responsible for repair 67, 99 . However, persistent appearance of M2 macrophages leads to improper repair and is strongly correlated with fibrosis in CKD 99 . Transformation of the macrophage phenotype is determined by the microenvironment in the interstitium.
Activated macrophages produce a variety of molecules, including tumor necrosis factor (TNF)-alpha, plateletderived growth factor (PDGF), basic fibroblast growth factor (FGF-2), TGF-β, and ROS, which induce further inflammation and fibrosis 101 . Soluble uric acid can stimulate the NLRP3 inflammasome/IL-1β pathway in macrophages and in turn activates cytokine production in tubular cells 102 . Again, the effects of macrophages on tubular cells and renal fibrosis depend on the polarization phenotype, as well as the stages after injury.
The effects of other inflammatory cells on fibrogenesis are less clear. It has been shown that T cells may play an initiation role in inflammation, as they precede the influx of macrophages into the kidney after injury 2 . High glucose-induced macrophage inflammatory protein-3 alpha from TECs is responsible for recruiting CD3 + cells to the interstitium 103 . A recent study has shed new insight on the roles of different subpopulations of T cells 104 . Researchers found that the depletion of either CD4 + or CD8 + T cells leads to aggravated renal fibrosis 104 . Accumulation of B cells in the kidney can promote monocyte/macrophage recruitment by the secretion of CCL2, thus aggravating renal fibrosis. NK cells and C3aR + cells are also positively correlated with TIF, but the mechanisms involved remain unclear 105, 106 . The complement is also activated during renal fibrosis 107 . An increased C5a level is observed in tubular cells in DN and is positively correlated with disease progression 108 . Local synthesis of the complement is also observed in PDGFRbeta-positive pericytes and CD45 (+) cells in the interstitium 109 . Thus, blocking synthesis or activation of the complement at different levels may offer benefits for renal fibrosis 107 . Tubular cells may also be part of the innate immune response. Released damage-associated molecular patterns can activate TECs by binding to their pattern recognition receptor, such as TLRs. Activated TECs can then produce cytokines or undergo pyroptosis, thus forming 
Crosstalk between TECs and the microvasculature
Intact microvasculature is a prerequisite for normal tubular structure and function. Peritubular capillaries and tubular cells are often injured together during renal injuries. Loss of peritubular capillaries is strongly correlated with renal fibrosis. A decrease in CD34
+ tubulointerstitial capillaries is observed together with TIF in the UUO model 73, 110 . However, it is hard to determine whether pericapillary injury is the cause or consequence of renal fibrosis. Capillary rarefaction results in hypoxia in tubular cells, thereby increasing oxidative stress in the interstitium. This, in turn, aggravates the damage in the microvasculature, forming a vicious cycle 75 . Tubular cells demand oxygen to fulfill their normal functions. Hypoxiainducible factor-1alpha (HIF-1alpha) and its downstream vascular endothelial growth factor (VEGF) are upregulated in TECs during hypoxia 111 . VEGF plays a dual role in the microvasculature. As a pro-angiogenic factor, it promotes endothelial cell survival and proliferation, thus enhancing peritubular capillary density 112 . However, excessive VEGF may result in the formation of leaky and nonfunctional vessels, which further aggravates hypoxia and oxidative stress in the interstitium 99 . Additionally, it is reported that VEGF can act as a proinflammatory factor that exacerbates renal fibrosis 99 . Secretion of antiangiogenic factors, such as endostatin and thrombospodin-1, by TECs can lead to microvasculature damage 72 , and this demonstrates the protective role of VEGF. Angiopoietin-1, a secreted vascular growth factor, ameliorates capillary rarefaction when overexpressed in TECs 113 . The close contact of pericytes with the endothelium is also important in maintaining capillary stability. A recent study demonstrates that ablation of pericytes alone could lead to endothelial damage and capillary rarefaction and further causes subclinical tubular cell injury, which is detected by expression of kidney injured molecule-1 and vimentin in TECs 114 . It is also reported that pericytes are a potential source of myofibroblasts. Pericytes can undergo a phenotype switch similar to EMT and acquire myofibroblast characteristics upon injury 115 . Thus, detachment of pericytes from the capillaries may further aggravate capillary rarefaction by forming more myofibroblasts.
Crosstalk between TECs and fibroblasts/myofibroblasts
Fibroblasts and myofibroblasts are the final executors of renal fibrosis. Upon injury, maladaptive TECs give rise to a switch in the microenvironment in the tubulointerstitial space in which myofibroblasts are activated. These activated executors are capable of producing substantial ECM, leading to TIF. TECs and myofibroblasts are at the two ends of the progression of renal fibrosis, the former as the initial reactor after injury and the latter as the final executor. Thus, understanding the crosstalk between these two cell types is of great importance.
Myofibroblasts are the activated form of fibroblasts, and they are characterized by the expression of alpha-smooth muscle actin (alpha-SMA), proliferation, and matrix production 2 . Recent studies have suggested five major origins of myofibroblasts, including resident fibroblasts, TECs, endothelial cells, pericytes, and bone marrowderived fibrocytes 2,4,115 . However, the exact contribution of each origin to renal fibrosis remains unclear. Tsutomu et al. reviewed several lineage-tracing experiments and found conflicting results regarding the contribution of EMT to renal fibrosis 82 . They proposed that the controversial results might be attributed to different disease models, mouse strains and types of genetic alterations used. They further demonstrated this hypothesis with four different models and confirmed that EMT-derived fibroblasts are activated in a disease-specific and straindependent manner 82 . In other words, in different conditions, the five origins of fibroblasts account for different proportions of intrarenal myofibroblasts. The different results could also be accounted for the inherent heterogeneity of myofibroblasts 2, 115 . The heterogeneity of myofibroblasts also leads to the lack of a specific marker to identify myofibroblasts 2 . Despite the conflicting origins, it has been a common view that myofibroblasts are mainly activated by a variety of cytokines and growth factors produced by TECs in a paracrine manner, including TGF-beta1, Wnt ligands, PDGF, hedgehog, hepatocyte growth factor, CTGF, and angiotensin II 99, [116] [117] [118] . Recent studies have shed light on some new factors produced by TECs, such as FGF-23. According to a recent study, FGF-23 could activate myofibroblasts derived from obstructed kidneys but fail to activate fibroblasts derived from normal kidneys 119 . FGF-23 could also induce ECM production in rat renal TECs (NRK-52E) via the TGF-β1 pathway 120 . Another study using immunofluorescence analysis also confirmed that TECs can act as an efficient producer of stable ECM 88 . The EGFR pathway is also involved in the TEC-fibroblast crosstalk. Persistent epithelial-specific activation of EGFR leads to epithelial dedifferentiation and cell cycle arrest, along with promoting proliferation of alpha-SMA + myofibroblasts 59 .
On the other hand, activated myofibroblasts can also exert profibrotic effects on tubular cells. Accumulation of ECM results in increased matrix rigidity and other biomechanical changes in the interstitium, which in turn leads to augmented levels of TGF-β1 expression and EMT 121 . ECM can also increase the diffusion distance of oxygen, thereby worsening hypoxia in TECs 4 . Microvesicles derived from fibroblasts can deliver miR-34a to tubular cells and induce tubular cell apoptosis 122 .
Final considerations
Growing numbers of studies have demonstrated that the long-neglected TECs are important mediators of TIF after injury. TECs can adopt different repair mechanisms to survive injury and recover normal kidney function. However, long-lasting stress makes these mechanisms maladaptive. The completion of fibrosis depends on crosstalk between TECs and other cells in the interstitium. Understanding the importance of TECs can help us further comprehend the complicated mechanisms of renal fibrosis. In the future, TECs may become new therapeutic targets to ameliorate or even reverse this process. Further investigations are needed in this field to explore the elaborate changes in TECs upon injury and how they interact with other cells to mediate renal fibrosis.
